Clinical Trials Browser

Gastro-enteropancreatic neuroendocrine tumor, Turcot syndrome, Tertiary Lymphoid Structures, Mesothelioma, Malignant, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Neoplasm Metastasis, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Triple Negative Breast Neoplasms

Clinical Trials

DNET

Beta plus

Early Identification of Cardiac Involvement in Patients With Carcinoid: Clinical and Prognostic Implications

177Lu-DOTA-EB-TATE in Adult Patients With Advanced, Well- Differentiated Neuroendocrine Tumors

Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine Neoplasms

Gallium-68 NODAGA-JR11 PECT/CT in Neuroendocrine Tumors

Radio-Marker

REGOMUNE

A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver

A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the Liver

Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

A Clinical Study to Assess the Combination of Two Drugs (177Lu-DOTATATE and Nivolumab) in Neuroendocrine Tumours

Dual SSTR2 and Integrin αvβ3 Targeting PET/CT Imaging

A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment (Liquid-NET 2.0)

Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine Neoplasm

Chidamide Plus Etoposide and Cisplatin/Carboplatin as First-line Treatment for Extrapulmonary Neuroendocrine Carcinoma

LOLA

MetNET-2

FENET-2016

Impact of Peptides and Chelators on Somatostatin Receptor Antagonists

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

DEBOXA for Inoperable NET Liver Metastases

A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors

A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors

POLNETS_PRRT

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Efficacy and Safety of 177Lu-Dotatate PRRT in Metastatic GEP-NEN Patients

Applying PET/MR in Neuroendocrine Tumors - Imaging Dynamic Processes in Both Modalities

Developing a Method Using PET-MR to Improve Staging and Monitoring of Neuroendocrine Tumor

68Ga-DOTATATE PET/CT in Neuroendocrine Tumor

Endoscopic Treatment of Rectal Neuroendocrine Tumor(NET) Less Than 10mm

Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type

Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NET

SANO

A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3

Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines)

Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue

A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms

177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors

Study to Compare Capecitabine Combined With Dacarbazine(CAPDTIC) Versus Capecitabine Combined Temozolomide(CAPTEM) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Tumor

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

EUS

LAB-2013-01

Nonfunctional Pancreatic NET and PET Imaging

Recombinant Anti-tumor and Anti-virus Protein for Injection to Treat Advanced Neuroendocrine Tumors

MetNet

EUS-FNA

68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors

124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors.

XELBEVOCT